These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7605217)

  • 21. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
    Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
    Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytogenetic variants of dysregenerative and precancerous epithelial changes in chronic inflammatory pulmonary diseases].
    Kogan EA; Paramonova NB; Demura SA; Popova EN
    Arkh Patol; 2003; 65(4):12-8. PubMed ID: 14518187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
    Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
    Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
    Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
    Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
    Shen J; Behrens C; Wistuba II; Feng L; Lee JJ; Hong WK; Lotan R
    Cancer Res; 2006 Dec; 66(23):11194-206. PubMed ID: 17145864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of neural-cadherin in pulmonary epithelial tumours.
    Zynger DL; Dimov ND; Ho LC; Laskin WB; Yeldandi AV
    Histopathology; 2008 Feb; 52(3):348-54. PubMed ID: 18269586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LKB1 protein expression in neuroendocrine tumors of the lung.
    Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
    Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The extracellular matrix of peripheral lung cancer in the scar and of pneumosclerosis of different origins (the immunohistochemistry and electron microscopy of the collagens)].
    Kogan EA; Sekamova SM; Tseĭtlin AM; Shukurova RA; Ovchinnikov AA; Rodionov KV; Trishkina NV
    Arkh Patol; 1991; 53(5):17-23. PubMed ID: 1652927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemical analysis of the tissue location of cytokines (IL-2 and IL-12) in neuroendocrine lung cancer.
    Kasprzak A; Przewoźna M; Zabel M; Pankowski J; Surdyk-Zasada J
    Folia Morphol (Warsz); 2003; 62(3):301-3. PubMed ID: 14507073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The DNA content in precancer, peripheral cancer and carcinoids of the lung (histospectrophotometric research)].
    Kogan EA; Rodionov KV; Trishkina NV; Dubrovskaia MI
    Arkh Patol; 1991; 53(6):17-24. PubMed ID: 1953357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
    Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
    Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroendocrine lung tumors].
    Ranfaing E
    Ann Pathol; 1993; 13(6):414-21. PubMed ID: 8141935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.